Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Bellicum Pharmaceuticals Inc.
DescriptionChimeric antigen receptor (CAR) T cell therapy targeting prostate stem cell antigen (PSCA) using GoCAR-T switch technology
Molecular Target Prostate stem cell antigen (PSCA)
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today